138 related articles for article (PubMed ID: 2160056)
21. Alterations in the N-methyl-D-aspartate receptor complex following focal cerebral ischemia.
Dewar D; Wallace MC; Kurumaji A; McCulloch J
J Cereb Blood Flow Metab; 1989 Oct; 9(5):709-12. PubMed ID: 2570787
[TBL] [Abstract][Full Text] [Related]
22. Glycine reverses 7-chlorokynurenic acid-induced inhibition of [3H]MK-801 binding.
Sircar R; Frusciante MJ; Javitt DC; Zukin SR
Brain Res; 1989 Dec; 504(2):325-7. PubMed ID: 2557130
[TBL] [Abstract][Full Text] [Related]
23. Glycine modulates [3H]MK-801 binding to the NMDA receptor in rat brain.
Wong EH; Knight AR; Ransom R
Eur J Pharmacol; 1987 Oct; 142(3):487-8. PubMed ID: 2828080
[No Abstract] [Full Text] [Related]
24. Involvement of the different rat hippocampal glutamatergic receptors in development of seizures induced by soman: an autoradiographic study.
Lallement G; Carpentier P; Pernot-Marino I; Baubichon D; Collet A; Blanchet G
Neurotoxicology; 1991; 12(4):655-64. PubMed ID: 1665552
[TBL] [Abstract][Full Text] [Related]
25. Kinetic mechanisms of glycine requirement for N-methyl-D-aspartate channel activation.
Sircar R; Zukin SR
Brain Res; 1991 Aug; 556(2):280-4. PubMed ID: 1682009
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of a radiolabelled derivative of the phencyclidine/N-methyl-D-aspartate receptor ligand (+) MK-801 with high specific radioactivity.
Keana JF; Scherz MW; Quarum M; Sonders MS; Weber E
Life Sci; 1988; 43(12):965-73. PubMed ID: 2845205
[TBL] [Abstract][Full Text] [Related]
27. Mode of binding of [3H]dibenzocycloalkenimine (MK-801) to the N-methyl-D-aspartate (NMDA) receptor and its therapeutic implication.
Kloog Y; Nadler V; Sokolovsky M
FEBS Lett; 1988 Mar; 230(1-2):167-70. PubMed ID: 2895019
[TBL] [Abstract][Full Text] [Related]
28. [3H]MK-801 binding sites in neonate rat brain.
Morin AM; Hattori H; Wasterlain CG; Thomson D
Brain Res; 1989 May; 487(2):376-9. PubMed ID: 2567199
[TBL] [Abstract][Full Text] [Related]
29. Cation interactions with putative NMDA receptor-gated channels labeled by [3H]MK-801 in rat cerebral cortex.
Greenberg DA; Marks SS
Neurosci Lett; 1988 Dec; 95(1-3):236-40. PubMed ID: 2852319
[TBL] [Abstract][Full Text] [Related]
30. Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors.
Rao TS; Kim HS; Lehmann J; Martin LL; Wood PL
Neuropharmacology; 1990 Mar; 29(3):225-30. PubMed ID: 2158000
[TBL] [Abstract][Full Text] [Related]
31. Role of lipid solubility in the interaction of drugs with the N-methyl-D-aspartate receptor.
Reynolds IJ; Rush EA
Synapse; 1990; 5(1):71-6. PubMed ID: 2154058
[TBL] [Abstract][Full Text] [Related]
32. The N-methyl-D-aspartate receptor complex.
Williams M; Loo PA; Murphy DE; Braunwalder AF; Jarvis MF; Sills MA
J Recept Res; 1988; 8(1-4):195-203. PubMed ID: 2455046
[TBL] [Abstract][Full Text] [Related]
33. The N-methyl-D-aspartate (NMDA) receptor complex: a stoichiometric analysis of radioligand binding domains.
Thedinga KH; Benedict MS; Fagg GE
Neurosci Lett; 1989 Sep; 104(1-2):217-22. PubMed ID: 2573014
[TBL] [Abstract][Full Text] [Related]
34. Role of hydrogen bonding in ligand interaction with the N-methyl-D-aspartate receptor ion channel.
Leeson PD; Carling RW; James K; Smith JD; Moore KW; Wong EH; Baker R
J Med Chem; 1990 May; 33(5):1296-305. PubMed ID: 1691788
[TBL] [Abstract][Full Text] [Related]
35. Contrasting neurochemical interactions of tiletamine, a potent phencyclidine (PCP) receptor ligand, with the N-methyl-D-aspartate-coupled and -uncoupled PCP recognition sites.
Rao TS; Contreras PC; Cler JA; Mick SJ; Dilworth VM; Iyengar S; Monahan JB; Wood PL
J Neurochem; 1991 Mar; 56(3):890-7. PubMed ID: 1847186
[TBL] [Abstract][Full Text] [Related]
36. PCP/NMDA receptor-channel complex and brain development.
Sircar R; Li CS
Neurotoxicol Teratol; 1994; 16(4):369-75. PubMed ID: 7526146
[TBL] [Abstract][Full Text] [Related]
37. [Excitatory amino-acids, a new class of neurotransmitters. Pharmacology and functional properties].
Krebs MO
Encephale; 1992; 18(3):271-9. PubMed ID: 1363728
[TBL] [Abstract][Full Text] [Related]
38. Subchronic administration of MK-801 in the rat decreases cortical binding of [3H]D-AP5, suggesting down-regulation of the cortical N-methyl-D-aspartate receptors.
Manallack DT; Lodge D; Beart PM
Neuroscience; 1989; 30(1):87-94. PubMed ID: 2568602
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and receptor binding studies of (+/-)1-iodo-MK-801.
Yang DJ; Ciliax BJ; Van Dort ME; Gildersleeve D; Pirat JL; Young AB; Wieland DM
Pharm Res; 1989 Jun; 6(6):474-6. PubMed ID: 2548173
[TBL] [Abstract][Full Text] [Related]
40. Interaction of [3H]MK-801 with multiple states of the N-methyl-D-aspartate receptor complex of rat brain.
Javitt DC; Zukin SR
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):740-4. PubMed ID: 2536176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
